Beta Innov

Pharmaceutical Research and Development

Development of innovative medicines with curative potential in Immunology and Cancer. Beta Innov SAS is an innovative Pharmaceutical Research and Development Company which was founded in March 2009 by patients’ families. Beta Innov’s objective is to achieve a major therapeutic leap forward in the treatment of some autoimmune diseases and of Glioblastoma through the use of a physiological (Immunology) or metabolic (Glioblastoma) approach, avoiding the cost of gene therapies and the adverse events resulting from antibody therapies.